Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.
R. Reilmann, A. McGarry, I. Grachev, J. Savola +115 more
2019Lancet Neurology87 citations
Semantic Scholar

